Vivoryon Therapeutics
Halle An Der Saale
About Vivoryon Therapeutics
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $212.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: ams:VVY
- Website: vivoryon.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/vivoryon-therapeutics-43717 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.